Brief: UK's MHRA Approves Eisai-Biogen's Alzheimer's drug

BioArctic AB

22/08/2024 10:00

Aug 22 (Reuters) - 
  
    * UK'S MHRA: LECANEMAB LICENSED FOR ADULT PATIENTS IN EARLY
STAGES
OF ALZHEIMER’S DISEASE
    * UK'S MHRA: TOGETHER WITH CONDITIONS OF LICENCE APPROVAL,
APPROPRIATE REGULATORY STANDARDS FOR LECANEMAB HAVE BEEN MET


Further company coverage:  4523.T 

 ((Reuters.Briefs@thomsonreuters.com;))